Webinar Overview

Drug development can be complex and challenging. Researchers need to be decisive, strategic, and timely with planning and execution. Furthermore, they face the challenges of translating scientific knowledge of a respective disease’s predisposition and progression to create an effective therapy and finding the best approach to develop a new drug.

These challenges, coupled with the goals of drug development, are what unites all companies, regardless of their size or budget. Part one of our webinar series will examine the pros and cons of various approaches of development strategies used by companies of various structures and sizes.

 

Scientific Moderator and Presenters

 

Sam Chuang, PhD
Director, Scientific Advisory Services
Charles River

Chris Murphy,PhD
VP Research and Development
Morningside Biopharma

Frank Brennan, PhD
Executive Director, Preclinical Safety
Novartis

 

View the other webinars in the series:

 

During this time of uncertainty, we are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.